Cocrystal Pharma (FRA:8CC) Cyclically Adjusted Book per Share: €22.25 (As of Mar. 2026)


FRA:8CC Cocrystal Pharma Inc FRA:8CC
22 GF Score
Price €0.90
! 3 Warning Signs
View Full Analysis

What is Cocrystal Pharma Cyclically Adjusted Book per Share?

Cocrystal Pharma FRA:8CC +0.56% 22 Cyclically Adjusted Book per Share is €22.25 as of Mar. 2026. GuruFocus rates FRA:8CC with a GF Score™ of 22/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Cocrystal Pharma's adjusted book value per share for the three months ended in Mar. 2026 was €0.258. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €22.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Cocrystal Pharma's average Cyclically Adjusted Book Growth Rate was -30.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Cocrystal Pharma was 15.70% per year. The lowest was -6.30% per year. And the median was 11.40% per year.

As of today (2026-07-03), Cocrystal Pharma's current stock price is €0.895. Cocrystal Pharma's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €22.25. Cocrystal Pharma's Cyclically Adjusted PB Ratio of today is 0.04.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cocrystal Pharma was 1.39. The lowest was 0.03. And the median was 0.10.


Cocrystal Pharma  (FRA:8CC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cocrystal Pharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.895/22.25
=0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Cocrystal Pharma was 1.39. The lowest was 0.03. And the median was 0.10.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Cocrystal Pharma Cyclically Adjusted Book per Share Related Terms


Cocrystal Pharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Cocrystal Pharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cocrystal Pharma Cyclically Adjusted Book per Share Chart

Cocrystal Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.77 30.94 37.01 58.90 23.76

Cocrystal Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.36 29.96 25.80 23.76 22.25

FRA:8CC vs HOOK, LNAI, CYCN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Cocrystal Pharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cocrystal Pharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cocrystal Pharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cocrystal Pharma's Cyclically Adjusted PB Ratio falls into.


FRA:8CC
22GF Score
Cocrystal Pharma Inc FRA:8CC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cocrystal Pharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cocrystal Pharma's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.258/330.2130*330.2130
=0.258

Current CPI (Mar. 2026) = 330.2130.

Cocrystal Pharma Quarterly Data

Book Value per Share CPI Adj_Book
201606 75.911 241.018 104.004
201609 75.405 241.428 103.135
201612 48.915 241.432 66.902
201703 47.143 243.801 63.852
201706 45.001 244.955 60.664
201709 41.472 246.819 55.484
201712 44.025 246.524 58.970
201803 41.542 249.554 54.969
201806 38.663 251.989 50.665
201809 38.108 252.439 49.849
201812 23.565 251.233 30.973
201903 24.794 254.202 32.208
201906 24.323 256.143 31.357
201909 24.378 256.759 31.352
201912 7.899 256.974 10.150
202003 8.421 258.115 10.773
202006 7.573 257.797 9.700
202009 7.455 260.280 9.458
202012 7.352 260.474 9.320
202103 7.342 264.877 9.153
202106 8.661 271.696 10.526
202109 8.478 274.310 10.206
202112 8.450 278.802 10.008
202203 8.226 287.504 9.448
202206 5.753 296.311 6.411
202209 5.446 296.808 6.059
202212 4.587 296.797 5.103
202303 3.977 301.836 4.351
202306 3.146 305.109 3.405
202309 2.827 307.789 3.033
202312 2.378 306.746 2.560
202403 2.042 312.332 2.159
202406 1.588 314.175 1.669
202409 1.125 315.301 1.178
202412 0.894 315.605 0.935
202503 0.664 319.799 0.686
202506 0.454 322.561 0.465
202509 0.501 324.800 0.509
202512 0.392 324.054 0.399
202603 0.258 330.213 0.258

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €22.25 mean?
Cocrystal Pharma (FRA:8CC) has a Cyclically Adjusted Book per Share of €22.25 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cocrystal Pharma and its competitors.
Is Cocrystal Pharma's Cyclically Adjusted Book per Share too high?
Cocrystal Pharma's current Cyclically Adjusted Book per Share is €22.25. Overall, Cocrystal Pharma has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cocrystal Pharma's Cyclically Adjusted Book per Share compare to HOOK and LNAI?
Cocrystal Pharma's Cyclically Adjusted Book per Share of €22.25 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Cocrystal Pharma and its competitors. Cocrystal Pharma's current Cyclically Adjusted Book per Share is €22.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cocrystal Pharma stock overvalued right now?
Cocrystal Pharma (FRA:8CC) has a current Cyclically Adjusted Book per Share of €22.25. The current Cyclically Adjusted Book per Share is €22.25. Cocrystal Pharma's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Cocrystal Pharma (FRA:8CC), the current Cyclically Adjusted Book per Share is €22.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cocrystal Pharma Business Description

Other Exchanges COCP:USA
Address 19805 North Creek Parkway, Bothell, WA, USA, 98011
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.
22GF Score

Get the complete analysis for FRA:8CC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.90
Price